Europe Animal Vaccines Market Size & Outlook, 2022-2030
Europe animal vaccines market, 2018-2030 (US$M)
Related Markets
Europe animal vaccines market highlights
- The Europe animal vaccines market generated a revenue of USD 3,210.2 million in 2022.
- The market is expected to grow at a CAGR of 9% from 2023 to 2030.
- In terms of segment, attenuated live vaccines was the largest revenue generating product in 2022.
- DNA Vaccines is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Germany is expected to register the highest CAGR from 2023 to 2030.
Europe data book summary
| Market revenue in 2022 | USD 3,210.2 million |
| Market revenue in 2030 | USD 6,378.0 million |
| Growth rate | 9% (CAGR from 2022 to 2030) |
| Largest segment | Attenuated live vaccines |
| Fastest growing segment | DNA Vaccines |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines |
| Key market players worldwide | Zoetis, Ceva Santé Animale, Merck & Co Inc, Vetoquinol SA, Boehringer Ingelheim, Elanco Animal Health Inc, Virbac SA, Veterinary Pharmaceutical Solutions, Dechra Pharmaceuticals, IDEXX Laboratories Inc, Norbrook |
Other key industry trends
- In terms of revenue, Europe region accounted for 25.0% of the global animal vaccines market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 6,412.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Animal Vaccines Market Scope
Animal Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe animal vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to animal vaccines market will help companies and investors design strategic landscapes.
Attenuated live vaccines was the largest segment with a revenue share of 37.7% in 2022. Horizon Databook has segmented the Europe animal vaccines market based on attenuated live vaccines, inactivated vaccines, subunit vaccines, dna vaccines, recombinant vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is the second-largest market for animal vaccines after North America. Increasing production of veterinary products in the region plays an important role in market growth. Animal vaccines can be an effective tool to reduce the necessity to use antibiotics in animals, thereby supporting the fight against antimicrobial resistance.
The European Medicines Agency (EMA) and its regulatory network partners identify an action plan to improve and increase the availability of animal medicines in Europe. There are some action plans being implemented in the interest of animal and public health and animal welfare.
Some initiatives are MUMS and restricted markets policy and support to Disease Control Tools project (DISCONTOOLS) analysis. These measures and initiatives increase availability of vaccines. Large pet population and improved animal husbandry practices are driving the growth of the market in the region.
Reasons to subscribe to Europe animal vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe animal vaccines market databook
-
Our clientele includes a mix of animal vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe animal vaccines market , including forecasts for subscribers. This continent databook contains high-level insights into Europe animal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe animal vaccines market size, by country, 2018-2030 (US$M)
Europe Animal Vaccines Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
